In conclusion, the results of this study suggest that miR-466 regulates the activities of NF-κB and Wnt/β-catenin pathways to inhibit the progression of HCC cells via targeting FMNL2. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.